Why the study?
Does stratified medicine guided by coronary function testing improve angina symptoms in patients with angina and nonobstructive CAD?
Does stratified medicine guided by coronary function testing improve angina symptoms in patients with angina and nonobstructive CAD?
No takes yet. Share an insight, caveat, or question.
The CorMicA trial is designed to evaluate whether a stratified medicine approach guided by invasive coronary function testing improves health status and outcomes in patients with angina and nonobstructive coronary artery disease.
Ford et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: